Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking
Open Access
- 30 August 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-12
Abstract
Burosumab, an FGF23 targeting monoclonal antibody, was approved by the FDA in 2018 for use in children and adults with X-linked hypophosphatemia (or XLH). While several clinical studies have demonstrated the long-term safety and efficacy of Burosumab, the molecular basis of FGF23-Burosumab interaction which underpins its mechanism of action remains unknown. In this study, we employed molecular docking combined with alanine scanning of epitope and paratope to predict a model of FGF23-Burosumab interaction. Then, we used the model to understand the species-species cross-reactivity of Burosumab and to reverse engineer mouse FGF23 with 'back to human' mutations to bind Burosumab. Finally, we redesigned the CDRs with two mutations to engineer an affinity enhanced variant of the antibody. Our study provides insights into the FGF23-Burosumab interaction and demonstrates that alanine-scanning coupled with molecular docking can be used to optimize antibody candidates (e.g., structure-guided affinity maturation) for therapeutic use.Keywords
All Related Versions
Funding Information
- Chulabhorn Graduate Institute, Chulabhorn Royal Academy
- Center of Excellence on Environmental Health and Toxicology
- Chulabhorn Research Institute
This publication has 32 references indexed in Scilit:
- Maximum Allowed Solvent Accessibilites of Residues in ProteinsPLOS ONE, 2013
- Serverification of Molecular Modeling Applications: The Rosetta Online Server That Includes Everyone (ROSIE)PLOS ONE, 2013
- Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factorMolecular BioSystems, 2013
- The Structural Biology of the FGF19 Subfamily2012
- Crystal contacts as nature's docking solutionsJournal of Computational Chemistry, 2009
- Toward high‐resolution homology modeling of antibody Fv regions and application to antibody–antigen dockingProteins: Structure, Function, and Bioinformatics, 2008
- Diversity and junction residues as hotspots of binding energy in an antibody neutralizing the dengue virusThe FEBS Journal, 2005
- Differences in Electrostatic Properties at Antibody–Antigen Binding Sites: Implications for Specificity and Cross-ReactivityBiophysical Journal, 2002
- The Protein Data BankNucleic Acids Research, 2000
- Antibody-antigen Interactions: Contact Analysis and Binding Site TopographyJournal of Molecular Biology, 1996